Blood Work for Pregnancy Confirmation and Management

Primary Confirmation Test

Serum beta-human chorionic gonadotropin (β-hCG) is the gold standard laboratory test for confirming pregnancy, becoming positive approximately 9 days after conception, as recommended by the American College of Radiology 1
Serum β-hCG tests can detect pregnancy earlier than urine tests, with most current tests having a sensitivity of 25 mIU/mL, according to the Centers for Disease Control and Prevention (CDC) 2

Complete blood count, blood typing and antibody screening, Hepatitis B surface antigen (HBsAg) screening, HIV, syphilis, and rubella testing, and fasting blood glucose are recommended as part of the initial prenatal workup, as suggested by the American College of Obstetricians and Gynecologists (ACOG) 3
Thyroid-stimulating hormone testing is particularly recommended in women with pre-existing diabetes, as advised by ACOG 3

In cases of suspected ectopic pregnancy, serial hCG measurements are crucial for monitoring, as abnormal patterns may indicate an ectopic implantation, according to the American College of Radiology 4
For women with chronic medical conditions, such as hypertension or diabetes, additional baseline laboratory tests, including renal function, liver enzymes, and uric acid levels, are recommended, as suggested by ACOG 3
In cases of unexplained persistent low-level elevated hCG, a structured workup is needed to rule out false positives, pituitary hCG, or hCG-producing tumors, as recommended by the National Comprehensive Cancer Network (NCCN) 4

Delaying additional recommended blood work after pregnancy confirmation can lead to delayed identification of potential complications, as warned by ACOG 3
Certain medical conditions or medications can affect hCG levels and interpretation, as noted by the American College of Radiology 4

Multiple marker screening, including AFP, hCG, uE3 with or without INH-A, should be offered between 16-18 weeks, unless amniocentesis is indicated, as recommended by the American College of Medical Genetics and Genomics (ACMG) 5
Maternal serum alpha-fetoprotein (MSAFP) screening for detection of open neural tube defects should be performed between 16-18 weeks, as advised by ACMG 5
Glucose challenge test for gestational diabetes screening at 24-28 weeks is recommended for average-risk women, as suggested by ACOG 3